annual cash & cash equivalents:
$163.50M-$43.09M(-20.86%)Summary
- As of today (September 16, 2025), EVH annual cash & cash equivalents is $163.50 million, with the most recent change of -$43.09 million (-20.86%) on December 31, 2024.
- During the last 3 years, EVH annual cash & cash equivalents has fallen by -$178.47 million (-52.19%).
- EVH annual cash & cash equivalents is now -57.32% below its all-time high of $383.04 million, reached on December 31, 2018.
Performance
EVH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$175.36M-$87.42M(-33.27%)Summary
- As of today (September 16, 2025), EVH quarterly cash & cash equivalents is $175.36 million, with the most recent change of -$87.42 million (-33.27%) on June 30, 2025.
- Over the past year, EVH quarterly cash & cash equivalents has increased by +$54.06 million (+44.57%).
- EVH quarterly cash & cash equivalents is now -55.85% below its all-time high of $397.18 million, reached on September 30, 2020.
Performance
EVH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EVH Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -20.9% | +44.6% |
3 y3 years | -52.2% | -34.4% |
5 y5 years | +33.0% | +20.1% |
EVH Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -52.2% | at low | -34.4% | +55.3% |
5 y | 5-year | -52.2% | +33.0% | -55.9% | +55.3% |
alltime | all time | -57.3% | >+9999.0% | -55.9% | >+9999.0% |
EVH Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $175.36M(-33.3%) |
Mar 2025 | - | $262.79M(+60.7%) |
Dec 2024 | $163.50M(-20.9%) | $163.50M(+44.8%) |
Sep 2024 | - | $112.93M(-6.9%) |
Jun 2024 | - | $121.30M(-44.0%) |
Mar 2024 | - | $216.74M(+4.9%) |
Dec 2023 | $206.59M(+1.9%) | $206.59M(-0.6%) |
Sep 2023 | - | $207.74M(+9.3%) |
Jun 2023 | - | $190.01M(+5.9%) |
Mar 2023 | - | $179.45M(-11.5%) |
Dec 2022 | $202.69M(-40.7%) | $202.69M(+11.5%) |
Sep 2022 | - | $181.81M(-32.0%) |
Jun 2022 | - | $267.45M(+7.1%) |
Mar 2022 | - | $249.81M(-27.0%) |
Dec 2021 | $341.96M(+2.6%) | $341.96M(+27.1%) |
Sep 2021 | - | $269.00M(+19.5%) |
Jun 2021 | - | $225.01M(-22.3%) |
Mar 2021 | - | $289.51M(-13.2%) |
Dec 2020 | $333.38M(+171.3%) | $333.38M(-16.1%) |
Sep 2020 | - | $397.18M(+172.0%) |
Jun 2020 | - | $146.00M(+18.0%) |
Mar 2020 | - | $123.77M(+0.7%) |
Dec 2019 | $122.89M | $122.89M(-39.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $202.02M(+53.7%) |
Jun 2019 | - | $131.44M(-40.7%) |
Mar 2019 | - | $221.74M(-42.1%) |
Dec 2018 | $383.04M(+27.3%) | $383.04M(+45.0%) |
Sep 2018 | - | $264.17M(+5.0%) |
Jun 2018 | - | $251.64M(+7.7%) |
Mar 2018 | - | $233.68M(-22.3%) |
Dec 2017 | $300.83M(+41.0%) | $300.83M(+2.9%) |
Sep 2017 | - | $292.21M(+117.6%) |
Jun 2017 | - | $134.26M(-16.7%) |
Mar 2017 | - | $161.23M(-24.4%) |
Dec 2016 | $213.32M(+33.4%) | $213.32M(+29.7%) |
Sep 2016 | - | $164.46M(+21.9%) |
Jun 2016 | - | $134.92M(-2.3%) |
Mar 2016 | - | $138.13M(-13.6%) |
Dec 2015 | $159.87M(>+9900.0%) | $159.87M(-24.4%) |
Sep 2015 | - | $211.50M(-5.5%) |
Jun 2015 | - | $223.76M(>+9900.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(-100.0%) | - |
Dec 2013 | - | $0.00 |
Dec 2012 | $5.25M | - |
FAQ
- What is Evolent Health, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Evolent Health, Inc.?
- What is Evolent Health, Inc. annual cash & cash equivalents year-on-year change?
- What is Evolent Health, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Evolent Health, Inc.?
- What is Evolent Health, Inc. quarterly cash & cash equivalents year-on-year change?
What is Evolent Health, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of EVH is $163.50M
What is the all time high annual cash & cash equivalents for Evolent Health, Inc.?
Evolent Health, Inc. all-time high annual cash & cash equivalents is $383.04M
What is Evolent Health, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, EVH annual cash & cash equivalents has changed by -$43.09M (-20.86%)
What is Evolent Health, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EVH is $175.36M
What is the all time high quarterly cash & cash equivalents for Evolent Health, Inc.?
Evolent Health, Inc. all-time high quarterly cash & cash equivalents is $397.18M
What is Evolent Health, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, EVH quarterly cash & cash equivalents has changed by +$54.06M (+44.57%)